中文名称:Low Density Lipoprotein英文名称:Low Density Lipoprotein 产品类别:重组蛋白 中文名称 【LDL】人低密度脂蛋白 英文名字 Low Density Lipoprotein 供应商 ProSpec 产品货号 PRO-562 产品报价 ￥3059/10mg ￥11270/100mg ￥70840/1gram 产品说明书
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment."Circulation. 2008; 117:3002–3009. Davidson M. "Is LDL-C Passed Its Prime? "ApolipoproteinB versus non-high-density lipoprotein cholesterol: and the winner is." Circulation.CPT Code...
Related to large low density lipoprotein particle: very low density lipoproteinpar·ti·cle (pär′tĭ-kəl) n. 1. A very small piece or part; a tiny portion or speck. 2. A very small or the smallest possible amount, trace, or degree: not a particle of doubt. 3. Physics a....
Very Low Density Lipoprotein (VLDL) is a type of lipoprotein that transports endogenous triglycerides and to a lesser extent cholesterol. It is associated with apolipoproteins B-100, C-I, C-II, C-III, and E. AI generated definition based on: Encyclopedia of Gastroenterology, 2004 ...
Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension. Clin Exp Hypertens... J Rubies-Prat,J Ordóez-Llanos,S Martin,... - 《Clinical & Experimental Hypertension》 被引量: 0发表: 2001年 LOW-DENSITY LIPOPROTEIN...
Low-density lipoprotein (LDL) is a type of lipoprotein that serves as a major carrier of cholesterol in the bloodstream, playing a crucial role in delivering cholesterol to cells through endocytosis. It is closely associated with heart disease and the accumulation of LDL is linked to the developm...
Low-density lipoprotein particle composition: what is the contribution to atherogenicity? (editorial) LL Rudel,YA Kesaniemi - 《Current Opinion in Lipidology》 被引量: 0发表: 2000年 Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young ...
Also, VLDL isolated from control and APOC1 transgenic mice were found to be equally good substrates for bovine lipoprotein lipase in vitro. These data indicate that the hyperlipidemia in APOC1 transgenic mice results primarily from impaired hepatic VLDL particle clearance, rather than a defect in ...
Considerable evidence has been presented suggesting that the mechanism for VLDL particle clearance involves cell surface binding and endocytic activities of either heparan sulfate proteoglycans (HSPG) [5–7] or the low density lipoprotein receptor-related protein (LRP) [8, 9], or both receptors actin...
Stimulation of VLDL-TG secretion did not lead to elevated plasma TG levels in C57BL/6J mice, indicating efficient particle metabolism and clearance. However, T0901317 treatment did lead to severe hypertriglyceridemia in mouse models of defective TG-rich lipoprotein clearance, i.e. APOE*3-Leiden ...